Levels of matrix metalloproteinase-9 within cerebrospinal fluid in a rabbit model of coccidioidal meningitis and vasculitis

Journal of Infectious Diseases

Volumn 186, Issue 11, 2002, Pages 1692-1695

  Williams, Paul L ^a,b,g   Leib, Stephen L ^e   Kamberi, Perparim ^b,c   Leppert, David ^f   Sobel, Raymond A ^c,d   Bifrare, Yoeng Delphine ^e   Clemons, Karl V ^b,c   Stevens, David A ^b,c  

^a Kaweah Delta Health Care District   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; INFLAMMATORY CELL; INFLAMMATORY DISEASE; MALE; NONHUMAN; PLEOCYTOSIS; PRIORITY JOURNAL; RABBIT; VASCULITIS; ZYMOGRAPHY;

ANIMALS; COCCIDIOIDES; DISEASE MODELS, ANIMAL; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MENINGITIS, FUNGAL; RABBITS; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 0036891393     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/345365     Document Type: Article

References (13)

1. Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metalloproteinases: Multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev 2001;36:249-57.
2. Leib SL, Leppert D, Clements J, Täuber MG. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 2000;68:615-20.
3. Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Holländer GA. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: Association with blood brain-barrier damage and neurological sequelae. Clin Infect Dis 2000;31:80-4.
4. Azeh I, Mäder M, Smirnov A, Beuche W, Nau R, Weber F. Experimental pneumococcal meningitis in rabbits: The increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leukocyte invasion. Neurosci Lett 1998;256:127-30.
5. Williams PL, Johnson R, Pappagianis D, et al. Vasculitic and encephalic complications associated with Coccidioides immitis infection of the central nervous system in humans: Report of 10 cases and review. Clin Infect Dis 1992;14:673-82.
6. Williams PL, Sobel RA, Sorensen KN, et al. A model of coccidioidal meningoencephalitis and cerebrospinal vasculitis in the rabbit. J Infect Dis 1998;178:1217-21.
7. Leppert D, Waubant E, Galardy R, Bunnett NW, Houser SL. T cell gelatinases mediate basement membrane transmigration in vitro. J Immun 1995;154:4379-89.
8. Kottirsch G, Koch G, Feifel R, Newmann U. β-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzymes. J Med Chem 2002;45:2289-93.
9. Sorensen KN, Sobel RA, Clemons KV, Pappagianis D, Stevens DA, Williams PL. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis. Antimicrob Agents Chemother 2000;44:1512-7.
10. Leib SL, Clements JM, Linberg RLP, et al. Inhibition of matrix metalloproteinases and tumor necrosis factor converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 2001;124:1734-42.
11. Ampel NM, Ahmann DR, Delgado, KL, Galgiani JN, Cloud GA. Tumor necrosis factor-α and interleukin-1β in cerebrospinal fluid of patients with coccidioidal meningitis during therapy with fluconazole. The National Institute of Allergy and Infectious Diseases Mycosis Study Group. J Infect Dis 1995;171:1675-8.
12. Matsuura E, Umehara F, Hashiguchi T, Fugimoto N, Okada Y, Osame M. Marked increase in matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningeal encephalitis. J Neurol Sci 2000;173:45-52.
13. Sorbi D, French DL, Nuovo GJ, Kew RR, Arbeit LA, Gruber BL. Elevated levels of 92-kD type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996;39:1747-53.